We are delighted to share that our patent has been officially granted.
This invention is part of our ongoing work in anti-inflammatory drug discovery, focused on targeting key molecular pathways involved in both acute and chronic inflammation. Our goal is to develop new therapies that can regulate overactive immune responses.
Diseases caused by uncontrolled inflammation remain a major global health challenge, contributing to conditions such as autoimmune disorders, chronic inflammatory diseases, and acute systemic conditions like sepsis. We believe this patented approach has strong potential to improve treatments for a range of inflammatory disorders.
We sincerely thank our research team and collaborators for their dedication and hard work in reaching this milestone. We look forward to advancing this innovation toward real-world impact.
-MSBLabIITI
